Skip to main content
TipRanks
Go Ultimate75% OFF

Robertet SA Cert.d'Invest. Em.87 (CBE) AI Stock Analysis

2 Followers
FR:CBE

Robertet SA Cert.d'Invest. Em.87

(Paris:CBE)

Select Model
Rating:63Neutral
Price Target:EUR 676.00â–²(8.82% Upside)
Action:reiterated
Date:09/23/26

Robertet earns a moderately above-average score anchored by sound fundamentals: consistent revenue and earnings growth, ~17% ROE, improving leverage and a strong 21.1% recurring EBITDA margin. The main drag is technical weakness, with the price trading below all major moving averages and a negative MACD signalling a persistent downtrend, though oversold momentum readings suggest the selling may be stretched. Valuation is supportive at a 15.4x P/E with a 1.9% dividend yield. The latest earnings call reinforces a balanced view: strong Fragrance, Health & Beauty and emerging-market momentum and maintained full-year guidance are tempered by slowing sequential organic growth, declines in Raw Materials and Flavors, FX and oil-linked cost headwinds, and uneven free cash flow conversion.

Positive Factors
Diversified growth from natural ingredients and international expansionStrong positioning in natural ingredients, premiumization and vertically integrated know-how gives Robertet multiple durable growth engines. Its broad catalog and expanding international footprint can strengthen customer relevance, support geographic diversification and reduce reliance on any single market over the next several quarters.
Negative Factors
Volatile cash-flow conversionPositive free cash flow is encouraging, but operating cash flow converting only slightly over half of net income in 2024–2025 signals uneven cash realization. Working-capital or investment swings can make internally generated funding less predictable and complicate capital allocation across future growth projects.

Robertet SA Cert.d'Invest. Em.87 (CBE) vs. iShares MSCI France ETF (EWQ)

-20%-15%-10%-5%0%5%10%15%FR:CBE-13.95%EWQ+1.77%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.64B
Dividend Yield
1.93%
Average Volume (3M)
19
Price to Earnings (P/E)
16.6
Beta (1Y)
0.45
Revenue Growth
0.30%
EPS Growth
0.78%
Country
France
Employees
2,750
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Robertet SA Cert.d'Invest. Em.87 Business Overview & Revenue Model

Company Description

Robertet SA specializes in the creation and distribution of fragrances, flavorings, and a diverse range of natural products. Its operations are strategically divided into three principal divisions: Raw Materials, Fragrances, and Flavors. The company...

Robertet SA Cert.d'Invest. Em.87 Earnings Call Summary

Earnings Call Date:Sep 17, 2026(Q2-2026)|% Change Since:-5.16%|Next Earnings Date:Apr 21, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Robertet delivered positive organic growth, strong Fragrance and Health and Beauty performance, robust profitability, improved operating cash flow, positive free cash flow, strong sustainability credentials, and continued international investment. The main challenges were the reported revenue decline, weaker Raw Materials and Flavors performance, currency and oil-related cost headwinds, a cautious mature-market environment, and limited M&A execution. Management nevertheless maintained its full-year growth and profitability objectives and reiterated its long-term growth ambitions.

Positive Updates

Positive Organic Growth Despite Moderate Market Conditions
Organic growth reached 2.8% in the first half despite adverse currency effects and contrasting divisional trends. Organic growth was 4.9% in the first quarter and 0.7% in the second quarter.

Negative Updates

Reported Revenue Decline
First-half revenue reached EUR 444 million, representing a 0.5% decline, primarily against a very strong first half of 2025. Currency effects reduced reported growth by 3 percentage points, mainly because of the strengthening euro against most group currencies, especially the U.S. dollar, while scope effects were slightly negative.

Company Guidance

For 2026, Robertet will target an organic growth of between +3% and +5% for the full-year, with an EBITDA above 21%; management also said the year to go will be between +4.7% and +7%, and that the second half will be a bit more pricing driven than volume driven. The company is targeting an EBIT in line with the past three years, clarified as being at the EBITDA level, not at the margin level, while its long-term guidance remains to be above 20%. CapEx is expected to remain between 4% and 5% of sales. Under Seed to Success 2030, Robertet wants to reach between EUR 1.1 billion and EUR 1.2 billion by 2030, implying an annual average growth of 5%-7% between 2025 and 2030, including EUR 50 million to EUR 80 million of revenues from targeted acquisitions over this period.

Robertet SA Cert.d'Invest. Em.87 Financial Statement Overview

Summary

Robertet shows solid fundamentals: multi-year revenue expansion to €844M, net income doubling to €103M, EBITDA margin near 20%, and ROE around 17%. Deleveraging has been meaningful, with debt-to-equity falling from ~0.72x to ~0.39x while equity grew to €603M. Offsetting these strengths are uneven cash flow generation, free cash flow conversion slipping to ~60% of net income on rising capital intensity, and an unusual gross margin fluctuation that clouds comparability.

Income Statement

72Positive

Balance Sheet

65Positive

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue841.88M843.93M807.61M721.13M703.04M606.09M
Gross Profit139.01M146.61M455.19M391.79M373.36M101.89M
EBITDA21.35M168.21M160.03M132.89M125.61M116.20M
Net Income99.08M103.43M90.07M74.60M76.02M71.71M
Balance Sheet
Total Assets1.08B1.00B1.01B927.13M847.21M783.29M
Cash, Cash Equivalents and Short-Term Investments176.98M180.67M193.47M172.59M128.06M190.01M
Total Debt256.71M233.33M268.00M325.63M297.87M112.73M
Total Liabilities430.01M399.53M456.07M460.72M431.43M237.39M
Stockholders Equity647.10M602.50M551.80M465.51M414.99M545.73M
Cash Flow
Free Cash Flow72.51M67.13M73.82M84.47M24.11M64.34M
Operating Cash Flow117.81M110.98M112.41M101.82M46.87M85.12M
Investing Cash Flow-76.15M-65.93M-38.33M-81.21M-67.36M-45.83M
Financing Cash Flow-60.10M-58.52M-58.93M-2.30M-43.28M-4.69M

Robertet SA Cert.d'Invest. Em.87 Technical Analysis

Technical Analysis SentimentNegative
Last Price621.20

Price Trends

50DMA633.28Negative
100DMA649.44Negative
200DMA671.23Negative

Market Momentum

MACD-2.16Positive
RSI42.90Neutral
STOCH1.52Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CBE, the sentiment is Negative. The current price of 621.20 is below the 20-day moving average (MA) of 626.35, below the 50-day MA of 633.28, and below the 200-day MA of 671.23, indicating a bearish trend. The MACD of -2.16 indicates Positive momentum. The RSI at 42.90 is Neutral, neither overbought nor oversold. The STOCH value of 1.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:CBE.

Robertet SA Cert.d'Invest. Em.87 Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

FR:CBE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
FR:CBEFR:CBE63NeutralEUR 1.62B16.58―1.93%0.30%0.78%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
FR:ALBKKFR:ALBKK55NeutralEUR 70.46M42.673.51%1.56%6.97%-73.50%
FR:ALAFYFR:ALAFY39UnderperformEUR 85.67M-11.16-7.49%―-13.62%54.46%

* Basic Materials Sector Average

Performance Comparison

-20%0%20%40%FR:CBEFR:ALAFYFR:ALBKKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
FR:CBE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
FR:CBERobertet SA Cert.d'Invest. Em.87621.20-100.73-13.95%
FR:ALAFYAFYREN2.21-0.04-2.00%
FR:ALBKKBaikowski SA19.20-3.52-15.51%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 23, 2026